Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
Auteur principal: | Tear, L |
---|---|
Autres auteurs: | Faulkner, S |
Format: | Thèse |
Langue: | English |
Publié: |
2018
|
Sujets: |
Documents similaires
-
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
par: T Mortezazadeh, et autres
Publié: (2020-02-01) -
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
par: Zahra Sahraei, et autres
Publié: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
par: Marco Moscatelli, et autres
Publié: (2023-10-01) -
Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
par: Caterina Beatrice Monti, et autres
Publié: (2020-04-01) -
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
par: Simona Bussi, et autres
Publié: (2020-02-01)